Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
2.
Value Health ; 26(6): 854-864, 2023 06.
Article in English | MEDLINE | ID: mdl-36709043

ABSTRACT

OBJECTIVES: Precision medicine is increasingly important in cancer treatment. Tumor-agnostic therapies are used regardless of tumor entity because they target specific biomarkers in tumors. In Germany, the benefit assessment of oncological pharmaceuticals has traditionally been entity specific. Thus, the assessment of tumor-agnostic therapies leaves stakeholders with various challenges. Our aim was to systematically identify challenges and possible solutions for the benefit assessment of therapies in tumor-agnostic indications using a 2-step sequential qualitative approach. METHODS: To identify relevant challenges, we conducted qualitative interviews with different stakeholders who were involved in previous benefit assessments of tumor-agnostic therapies in Germany. To identify possible solutions for these challenges, we systematically searched MEDLINE, Embase, and the websites of European health technology assessment bodies for relevant literature. RESULTS: We identified 9 categories of challenges of which the following were deemed particularly relevant: the absence of direct comparative studies, challenges regarding the use of basket studies and indirect comparisons, challenges in determining the appropriate comparative therapy in a tumor-agnostic indication, and challenges on the system side. Seven categories of solutions were identified, including an increased use of real-world evidence, making conditional decisions in the context of systematic reassessments, splitting the field of application, and finding (new) ways to design and analyze basket studies. CONCLUSION: A range of possible solutions, which can help to meet the identified challenges in Germany, have been found. Future research should investigate the acceptance and feasibility of these solutions.


Subject(s)
Neoplasms , Humans , Germany , Medical Oncology , Neoplasms/therapy , Precision Medicine
3.
Eur J Appl Physiol ; 121(11): 3017-3030, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34251539

ABSTRACT

PURPOSE: The purpose of the present study was to examine the effect of repeated, single leg heating on lower limb endothelial function. METHODS: Macrovascular function was assessed with superficial femoral artery (SFA) reactive hyperemia flow-mediated dilation (RH-FMD) and sustained stimulus FMD (SS-FMD). Calf microvascular function was assessed as the peak and area under the curve of SFA reactive hyperemia (RH). Participants (n = 13 females, 23 ± 2 yrs) had one leg randomized to the single leg heating intervention (EXP; other leg: control (CON)). The EXP leg underwent 8 weeks of single leg heating via immersion in 42.5 â„ƒ water for five 35-min sessions/week. At weeks 0, 2, 4, 6, and 8, SFA RH-FMD, SS-FMD (shear stress increased via plantar flexion exercise), and SFA RH flow were measured. RESULTS: None of the variables changed with repeated, single leg heating (interaction week*limb RH-FMD: p = 0.076; SS-FMD: p = 0.958; RH flow p = 0.955). Covariation for the shear stress stimulus did not alter the FMD results. CONCLUSION: Eight weeks of single leg heating did not change SFA endothelial or calf microvascular function. These results are in contrast with previous findings that limb heating improves upper limb endothelial function.


Subject(s)
Blood Flow Velocity/physiology , Endothelium, Vascular/physiology , Femoral Artery/physiology , Hot Temperature , Leg/blood supply , Regional Blood Flow/physiology , Female , Humans , Hyperemia , Young Adult
4.
BMC Infect Dis ; 11: 73, 2011 Mar 22.
Article in English | MEDLINE | ID: mdl-21426562

ABSTRACT

BACKGROUND: Human papillomavirus is responsible for a variety of diseases including grade 2 and 3 vulvar and vaginal intraepithelial neoplasia. The aim of this study was to assess parts of the burden of the last diseases including treatment costs. The direct medical resource use and cost of surgery associated with neoplasia and related diagnostic procedures (statutory health insurance perspective) were estimated, as were the indirect costs (productivity losses) associated with surgical treatment and related gynaecology visits for diagnostic purposes. METHODS: Data from 1991-2008 were retrospectively collected from patient records of the outpatient unit of the Gynaecological Dysplasia Clinic, Heinrich Heine University, Dusseldorf, Germany. Two subgroups of patients were analysed descriptively: women undergoing one surgical procedure related to a diagnosis of vulvar and/or vaginal intraepithelial neoplasia, and women undergoing two or more surgical procedures. Target measures were per-capita medical resource consumption, direct medical cost and indirect cost. RESULTS: Of the 94 women analysed, 52 underwent one surgical intervention and 42 two or more interventions (mean of 3.0 interventions during the total period of analysis). Patients undergoing one surgical intervention accrued €881 in direct costs and €682 in indirect costs; patients undergoing more than one intervention accrued €2,605 in direct costs and €2,432 in indirect costs. CONCLUSIONS: The economic burden on German statutory health insurance funds and society induced by surgical interventions and related diagnostic procedures for grade 2/3 vulvar and vaginal neoplasia should not be underrated. The cost burden is one part of the overall burden attributable to human papillomavirus infections.


Subject(s)
Papillomavirus Infections/economics , Uterine Cervical Dysplasia/economics , Vaginal Neoplasms/economics , Vulvar Neoplasms/economics , Adult , Aged , Aged, 80 and over , Costs and Cost Analysis , Female , Germany , Humans , Insurance, Health/economics , Middle Aged , Papillomavirus Infections/therapy , Retrospective Studies , Vaginal Neoplasms/therapy , Vaginal Neoplasms/virology , Vulvar Neoplasms/therapy , Vulvar Neoplasms/virology , Young Adult , Uterine Cervical Dysplasia/therapy , Uterine Cervical Dysplasia/virology
5.
Magn Reson Med ; 64(4): 1162-70, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20564601

ABSTRACT

Dynamic contrast-enhanced MRI (or DCE-MRI) is a useful tool for measuring blood flow and perfusion, and it has found use in the study of pulmonary perfusion in animal models. However, DCE-MRI experiments are difficult in small animals such as rats. A recently developed method known as Interleaved Radial Imaging and Sliding window-keyhole (IRIS) addresses this problem by using a data acquisition scheme that covers (k,t)-space with data acquired from multiple bolus injections of a contrast agent. However, the temporal resolution of IRIS is limited by the effects of temporal averaging inherent in the sliding window and keyhole operations. This article describes a new method to cover (k,t)-space based on the theory of partially separable functions (PSF). Specifically, a sparse sampling of (k,t)-space is performed to acquire two data sets, one with high-temporal resolution and the other with extended k-space coverage. The high-temporal resolution training data are used to determine the temporal basis functions of the PSF model, whereas the other data set is used to determine the spatial variations of the model. The proposed method was validated by simulations and demonstrated by an experimental study. In this particular study, the proposed method achieved a temporal resolution of 32 msec.


Subject(s)
Algorithms , Image Interpretation, Computer-Assisted/methods , Magnetic Resonance Angiography/methods , Models, Cardiovascular , Pulmonary Artery/physiology , Pulmonary Circulation/physiology , Animals , Blood Flow Velocity/physiology , Computer Simulation , Female , Image Enhancement/methods , Pulmonary Artery/anatomy & histology , Rats , Rats, Inbred F344 , Reproducibility of Results , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...